Editorial
doi: 10.1001/jama.284.2.236.
Interleukin 2 treatment for HIV infection
- PMID: 10889599
- DOI: 10.1001/jama.284.2.236
Item in Clipboard
Editorial
Interleukin 2 treatment for HIV infection
JAMA.
.
No abstract available
Comment on
-
Immune restoration with antiretroviral therapies: implications for clinical management.JAMA. 2000 Jul 12;284(2):223-8. doi: 10.1001/jama.284.2.223. JAMA. 2000. PMID: 10889597
Similar articles
-
[Therapy of HIV infection: combination drug therapy effective, immunotherapy still experimental].Dtsch Med Wochenschr. 1997 Apr 11;122(15):A32. Dtsch Med Wochenschr. 1997. PMID: 9147936 German. No abstract available.
-
Interleukin-2 in combination with zidovudine and didanosine is able to maintain high levels of CD4 cells and undetectable HIV viraemia.AIDS. 1998 Jan 1;12(1):112-3. AIDS. 1998. PMID: 9456263 Clinical Trial. No abstract available.
-
IL-2 plus HAART reduces HIV in immune system "hiding places".WORLD. 1998 Dec;(No 92):7. WORLD. 1998. PMID: 11365976
-
Aldesleukin therapy in HIV-infected patients.Am J Health Syst Pharm. 1998 Jul 15;55(14):1520-3. doi: 10.1093/ajhp/55.14.1520. Am J Health Syst Pharm. 1998. PMID: 9676300 Review. No abstract available.
-
Interleukin-2 for the management of HIV infection.J Am Pharm Assoc (Wash). 1999 Nov-Dec;39(6):867-8. J Am Pharm Assoc (Wash). 1999. PMID: 10609454 Review. No abstract available.
Cited by
-
Interleukin-2 as an adjunct to antiretroviral therapy for HIV-positive adults.Cochrane Database Syst Rev. 2017 May 25;5(5):CD009818. doi: 10.1002/14651858.CD009818.pub2. Cochrane Database Syst Rev. 2017. PMID: 28542796 Free PMC article. Review.
-
An anti-CD45RO immunotoxin kills HIV-latently infected cells from individuals on HAART with little effect on CD8 memory.Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2494-9. doi: 10.1073/pnas.0308381100. Proc Natl Acad Sci U S A. 2004. PMID: 14983037 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
